- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.12.25 | Citizen Health and UCB collaborate for epilepsy drug development | ||
| 02.12.25 | FDA steps back from preclinical primate testing amid wider regulatory shift | ||
| 02.12.25 | WHO backs use of GLP-1RAs for weight loss despite shortage warning | ||
| 02.12.25 | House passes bill that reauthorises the FDA's paediatric priority voucher pathway | ||
| 02.12.25 | Solid Biosciences' SGT-212 gains FDA rare paediatric disease status | ||
| 02.12.25 | Lotus submits NDA for VIZZ in South Korea to treat presbyopia | ||
| 01.12.25 | UK and US strike "landmark" zero-tariff pharma deal | ||
| 01.12.25 | Regeneron and Tessera join forces to forge in vivo AATD gene therapy | ||
| 01.12.25 | "Sharp" funding cuts disrupt PrEP access to millions of HIV patients | ||
| 01.12.25 | Eisai seeks PMDA approval for subcutaneous Leqembi in Japan | ||
| 01.12.25 | US FDA approves Lupin's Armlupeg injection | ||
| 28.11.25 | WHO warns of immunisation strategy gaps amid measles outbreaks | ||
| 28.11.25 | Celltrion secures Health Canada go-ahead for Eylea biosimilar | ||
| 28.11.25 | Over half of European HIV patients diagnosed late, ECDC report finds | ||
| 28.11.25 | IASO Bio gains Hong Kong approval for Fucaso application | ||
| 27.11.25 | Valneva trims R&D footprint by shutting French facility | ||
| 27.11.25 | SK bolsters oncology pipeline in radiopharmaceutical licensing deal | ||
| 27.11.25 | BeOne's sonrotoclax gains priority FDA review for mantle cell lymphoma | ||
| 27.11.25 | Corstasis Therapeutics partners CVL for Enbumyst integration | ||
| 26.11.25 | Reeves' Autumn Budget targets community health centres and NHS tech outlay | ||
| 26.11.25 | Dupixent gains chronic spontaneous urticaria indication in Europe | ||
| 26.11.25 | Questions on how new IRA drug prices will affect MFN agreements | ||
| 26.11.25 | Novartis axes 550 jobs at Swiss manufacturing site | ||
| 26.11.25 | UNICEF and Gavi to widen affordable malaria vaccine access | ||
| 26.11.25 | FDA grants accelerated approval for Otsuka's IgAN therapy |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.